United States Food and Drug Administration (USFDA) has conducted an inspection of Jeevan Scientific Technology’s bioanalytical facility, at Manikonda, Hyderabad. The purpose of the inspection was to review the BA/BE studies as well as the operations, systems and procedures. The inspection was conducted during July 20, 2026 to July 24, 2026 and closed with No Observations (Zero 483s).
The inspector concluded that the entire company’s team is well trained, knowledgeable and experienced with International Regulatory requirements and Good practices, working within an adequately designed infrastructure and that the organization is compliant with all applicable regulations.
Jeevan Scientific Technology was incorporated on February 2, 1999 to carry on the business Clinical research, Data management services. The company is an Independent Clinical Contract Research Organization, offering reliable, cost-effective and technology-driven clinical research solutions to various Clients across the globe.
